ClinicalTrials.Veeva

Menu

Auricular Transcutaneous Electrical Nerve Stimulation Treatment of Autism

Mass General Brigham logo

Mass General Brigham

Status

Not yet enrolling

Conditions

Autism Spectrum Disorder

Treatments

Other: 1 Hz Auricular transcutaneous electrical nerve stimulation
Other: 20 Hz Auricular transcutaneous electrical nerve stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT03827941
2017P000894

Details and patient eligibility

About

In this study, investigators will examine the treatment effects of transcutaneous electrical nerve stimulation with different stimulation frequencies on individuals with autism.

Full description

In this study, investigators will examine the treatment effect of transcutaneous electrical nerve stimulation at auricular area with vagus nerve distribution on high-functioning individuals with autism. Specifically, investigators will choose two ear acupoints: heart and shenmen. Participants will be randomized to either 1 Hz or 20 Hz tVNS group (up to 5 times per week) for three weeks.

Enrollment

40 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Autism diagnosed based on DSM-V classification criteria
  2. 18-60 year old high functioning adult autism patients (e.g. Asperger's, IQ equal or greater than 80)
  3. Subjects who do not show aggressive behaviors based on neuro/psychiatric evaluations as determined by a licensed study physician.

Exclusion criteria

  1. A history of chronic serious infection, any current infection, any type of cancer or autoimmune disease or other severe diseases;
  2. Subjects taking any medications that confound the study results

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

40 participants in 2 patient groups

1 Hz group
Active Comparator group
Description:
1 Hz Auricular transcutaneous electrical nerve stimulation High-functioning individuals with autism randomized to this group will receive 1 Hz tVNS stimulation for 30 minutes/day up to 5 times/week for 3 weeks.
Treatment:
Other: 1 Hz Auricular transcutaneous electrical nerve stimulation
20 Hz group
Active Comparator group
Description:
20 Hz Auricular transcutaneous electrical nerve stimulation High-functioning individuals with autism randomized to this group will receive 20 Hz tVNS stimulation for 30 minutes/day up to 5 times/week for 3 weeks.
Treatment:
Other: 20 Hz Auricular transcutaneous electrical nerve stimulation

Trial contacts and locations

0

Loading...

Central trial contact

Amy Ursitti

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems